HUNT and SomaLogic in CV biomarker collaboration; Cardiac biomarkers predict stroke;

> HUNT Biosciences and SomaLogic have created a biomarker collaboration, initially focusing on the validation of biomarkers for the prediction of cardiovascular events such as strokes, heart attacks and heart failure. Press release

> Two known cardiac biomarkers can improve the prediction of stroke or other risk in patients with nonvalvular atrial fibrillation. Article

> Circulating microvesicles could be useful in cancer diagnosis, according to posters presented at AACR. Press release

> Lipid-coated, targeted quantum dots could help researchers detect cancer biomarkers. Article

> Researchers find possible urinary biomarkers of kidney function in a mouse transcriptome. Abstract

> NextGen has launched PLASMAassay-human A.1.0, its assay to detect 52 cancer and CNS biomarkers simultaneously. Press release

> Antibody manufacturer GeneTex is launching a new antibody against CAIX, a hypoxia biomarker, for use in cancer research. Press release

> Ridge Diagnostics and Ameritox have hooked up, with Ridge licensing rights to Ameritox's developmental blood test MDDScore, a multiple biomarker assay for major depressive disorder. Press release

> A literature review has suggested that cytochrome C could have potential as a biomarker of acute kidney injury. Abstract

> In a focus on glioblastoma, researchers from the Case Medical Center and Case Western Reserve University presented a mammoth 24 papers and posters, including data on biomarkers, at this year's American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago. Press release

And Finally… Two liver journals have retracted self-plagiarized biomarker papers from a group of Irani researchers. Blog post

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.